TR201618030T2 - Tadı düzeltilmiş parasetamol formülasyonları. - Google Patents

Tadı düzeltilmiş parasetamol formülasyonları.

Info

Publication number
TR201618030T2
TR201618030T2 TR2016/18030T TR201618030T TR201618030T2 TR 201618030 T2 TR201618030 T2 TR 201618030T2 TR 2016/18030 T TR2016/18030 T TR 2016/18030T TR 201618030 T TR201618030 T TR 201618030T TR 201618030 T2 TR201618030 T2 TR 201618030T2
Authority
TR
Turkey
Prior art keywords
tastedly
corrected
paracetamol
paracetamol formulations
formulations
Prior art date
Application number
TR2016/18030T
Other languages
English (en)
Inventor
Gi̇deroz Tuba
Kandemi̇rer Ürün
Odabaşi Serap
Original Assignee
Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi
Publication of TR201618030T2 publication Critical patent/TR201618030T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu buluş, acı tada sahip parasetamol etkin maddesini içeren fannasötik formülasyonların tadının metal tuzlan kullanılarak iyileştirilmesi ile ilgilidir.
TR2016/18030T 2014-08-14 2015-08-13 Tadı düzeltilmiş parasetamol formülasyonları. TR201618030T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201409474 2014-08-14
PCT/TR2015/000305 WO2016024928A1 (en) 2014-08-14 2015-08-13 Taste masked paracetamol formulations

Publications (1)

Publication Number Publication Date
TR201618030T2 true TR201618030T2 (tr) 2018-09-21

Family

ID=54065431

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2016/18030T TR201618030T2 (tr) 2014-08-14 2015-08-13 Tadı düzeltilmiş parasetamol formülasyonları.

Country Status (2)

Country Link
TR (1) TR201618030T2 (tr)
WO (1) WO2016024928A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019202521A1 (en) 2018-04-18 2019-10-24 Shilpa Medicare Limited Oral disintegrating film compositions of paracetamol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
US5272137A (en) 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
WO1995000133A1 (en) 1993-06-25 1995-01-05 Ibah, Inc. Taste-masked acetaminophen suspensions and methods of making the same
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
WO2004052345A1 (en) 2002-12-11 2004-06-24 Ranbaxy Laboratories Limited Coating composition for taste masking coating and methods for their application and use
WO2004087111A1 (en) 2003-04-04 2004-10-14 Ranbaxy Laboratories Limited Oral taste masked pharmaceutical compositions
US20070249727A1 (en) * 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
WO2013175511A1 (en) * 2012-05-24 2013-11-28 V.B. Medicare Pvt. Ltd. Taste masked pharmaceutical compositions

Also Published As

Publication number Publication date
WO2016024928A1 (en) 2016-02-18

Similar Documents

Publication Publication Date Title
MX376083B (es) Formas de dosificacion solidas de palbociclib.
MY195681A (en) Aqueous Pharmaceutical Formulation Comprising Anti-Pd-L1 Antibody Avelumab
MX383227B (es) Vectores de virus adenoasociados para el tratamiento de trastornos de almacenamiento lisosomico.
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX386615B (es) Vectores virales adenoasociados para el tratamiento de mucopolisacaridosis.
BR112016021012A2 (pt) composições farmacêuticas de compostos terapeuticamente ativos.
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
EA201790847A1 (ru) Композиции и способы лечения с применением пролекарств тизоксанида, его аналога или соли
MX387402B (es) Formulaciones eutécticas de clorhidrato de ciclobenzaprina.
MX389178B (es) Formulacion de proporcion fija de insulina glargina/lixisenatida.
EA201790650A1 (ru) Лекарственная форма и способы применения абиратерона ацетата
BR112017028549A2 (pt) derivados de pirimidina como inibidores de btk e usos dos mesmos
EA201500821A1 (ru) Производные 2-замещенных-6-биарилметиламино-9-циклопентил-9н-пуринов, их использование в качестве лекарственных средств и фармацевтических составов
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
MX2016011938A (es) Composicion farmaceutica liquida.
CY1122473T1 (el) Βελτιστοποιημενο μεσαλαζiνουχο δισκιο υψηλης δοσης
MX394123B (es) Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos
EA201792262A1 (ru) Пироглутамат вортиоксетина
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
BR112017009289A2 (pt) métodos de administrar composições de amantadina
IN2014CH00840A (tr)